IMAX Corporation
NYSE:IMAXEntertainment
+$0.46 today
- Market cap
- $2.58B
- Beta
- 0.37
- P/E (TTM)
- 65.9
- EPS (TTM)
- $0.68
Volume 0.95M
Average 1.13M
IMAX Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
IMAX CorporationNYSE: IMAX
Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026
Cash & equivalents rises 45.3% from a year ago
Cash & equivalents stood at $207.92M at the end of Q3 FY2026, up 45.3% from a year earlier and up 30.0% from the prior quarter. Over 3 fiscal years it compounded at +15.8% a year.
Context
- Cash & equivalents amounted to 20.2% of total assets at the end of Q3 FY2026, up 4.1 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +45.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 151.17M USD
- Year-over-year change
- +50.3%
- 4-year CAGR
- -5.5%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 151.17M | +50.3% |
| FY2024 | 2024-12-31 | 100.59M | +32.0% |
| FY2023 | 2023-12-31 | 76.2M | -21.8% |
| FY2022 | 2022-12-31 | 97.4M | -48.7% |
| FY2021 | 2021-12-31 | 189.71M | — |
Cash & Equivalents vs competitors
How IMAX compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +45.3% is the 4th highest of 9, against a peer median of +31.0%.
- Cash & equivalents amounts to 20.2% of total assets for IMAX, versus a peer median of 8.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CN¥2.94B CNY | -31.9% | -14.9% | 6.4% | |
| Jun 2026 | $778.4M USD | +83.7% | -12.1% | 9.7% | |
| Jun 2026 | $552.02M USD | +1183.3% | +93.6% | 13.7% | |
| Jun 2026 | $425.8M USD | +128.8% | -4.7% | 8.0% | |
| Sep 2026 | $207.92M USD | +45.3% | +15.8% | 20.2% | |
| Mar 2026 | $189M USD | +3.3% | -5.5% | 9.2% | |
| Jul 2026 | $106.43M USD | +30.0% | -10.8% | 3.4% | |
| Sep 2026 | $97.85M USD | +10.5% | -17.0% | 3.2% | |
| Jun 2026 | $77.72M USD | +32.0% | -1.8% | 20.0% | |
| Peer median (excluding IMAX) | — | +31.0% | -8.2% | 8.6% | |
Competitors are the stored peer set for IMAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 189.71M | 97.4M | 76.2M | 100.59M | 151.17M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 295.32M | 309.55M | 327.75M | 310.15M | 138.74M |
| Inventory | 26.92M | 31.53M | 31.58M | 32.84M | 32.51M |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 523.75M | 450.83M | 447.88M | 456.7M | 337.29M |
| Property, Plant & Equipment (Net) | 260.35M | 252.9M | 243.3M | 240.13M | 242.91M |
| Goodwill | 39.03M | 52.82M | 52.82M | 52.82M | 45.82M |
| Intangible Assets | 27.32M | 38.02M | 41.81M | 43.81M | 32.39M |
| Long-term Investments | 2.09M | 2.04M | 1M | 1M | 183.69M |
| Tax Assets | 13.91M | 9.9M | 7.99M | 14.5M | 12.58M |
| Other Non-current Assets | 16.8M | 14.67M | 19.88M | 21.44M | 39.36M |
| Total Non-current Assets | 359.49M | 370.33M | 366.79M | 373.7M | 556.74M |
| Total Assets | 883.25M | 821.15M | 814.67M | 830.4M | 894.03M |
| Account Payables | 15.94M | 25.24M | 26.39M | 19.8M | 19.48M |
| Short-term Debt | 2.47M | 36.11M | 22.92M | 39.23M | 37.9M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 81.28M | 70.94M | 67.11M | 52.69M | 50.4M |
| Other Current Liabilities | 0 | 0 | 0 | 84.86M | 89.83M |
| Total Current Liabilities | 211.59M | 249.57M | 227.43M | 200.77M | 202.01M |
| Long-term Debt | 223.64M | 226.91M | 229.13M | 229.9M | 251.77M |
| Deferred Tax Liabilities | 17.64M | 14.9M | 12.52M | 12.52M | 12.52M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | (7.74M) |
| Total Non-current Liabilities | 241.28M | 241.81M | 241.65M | 251.41M | 264.29M |
| Total Liabilities | 452.88M | 491.39M | 469.08M | 452.18M | 466.3M |
| Common Stock | 409.98M | 376.72M | 389.05M | 401.42M | 419.16M |
| Retained Earnings | (234.98M) | (293.12M) | (292.85M) | (274.68M) | (239.97M) |
| Accumulated OCI | 6.46M | (5.91M) | (8.15M) | (12.55M) | (10.31M) |
| Other Stockholders Equity | 174.62M | 185.68M | 185.09M | 185.27M | 169M |
| Minority Interest | 74.29M | 66.41M | 72.45M | 78.75M | 89.84M |
| Total Equity | 430.37M | 329.77M | 345.59M | 378.22M | 427.73M |
| Total Debt | 226.11M | 263.02M | 252.06M | 278.12M | 297.41M |
| Net Debt | 36.4M | 165.62M | 175.86M | 177.53M | 146.25M |
IMAX Corporation
NYSE:IMAX
Intrinsic Alpha fair value
Locked
Current Price
$46.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.